PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $4,557,000 | -72.4% | 639,100 | -7.7% | 0.02% | -65.3% |
Q4 2019 | $16,530,000 | -8.7% | 692,192 | +2.5% | 0.05% | +6.5% |
Q3 2019 | $18,104,000 | +20.7% | 675,002 | +22.1% | 0.05% | -6.1% |
Q2 2019 | $14,994,000 | -7.9% | 552,657 | +17.8% | 0.05% | -10.9% |
Q1 2019 | $16,281,000 | +263.2% | 469,187 | +177.8% | 0.06% | +243.8% |
Q4 2018 | $4,483,000 | 0.0% | 168,914 | +0.2% | 0.02% | 0.0% |
Q3 2018 | $4,483,000 | +5958.1% | 168,540 | +8451.0% | 0.02% | – |
Q2 2018 | $74,000 | -22.1% | 1,971 | -32.8% | 0.00% | – |
Q1 2018 | $95,000 | -65.3% | 2,932 | -48.0% | 0.00% | -100.0% |
Q4 2017 | $274,000 | +26.3% | 5,635 | +40.5% | 0.00% | 0.0% |
Q3 2017 | $217,000 | -71.6% | 4,010 | -73.0% | 0.00% | -80.0% |
Q4 2015 | $765,000 | -45.1% | 14,871 | -54.5% | 0.01% | -61.5% |
Q3 2015 | $1,393,000 | +126.9% | 32,671 | +142.2% | 0.01% | +116.7% |
Q2 2015 | $614,000 | +66.4% | 13,488 | +38.6% | 0.01% | +100.0% |
Q1 2015 | $369,000 | – | 9,733 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,220,672 | $52,025,000 | 8.00% |
Fernwood Investment Management, LLC | 190,011 | $8,098,000 | 7.10% |
Cormorant Asset Management, LP | 500,000 | $21,310,000 | 3.40% |
HARVEY CAPITAL MANAGEMENT INC | 157,930 | $6,730,000 | 2.69% |
Atika Capital Management LLC | 128,000 | $5,456,000 | 2.68% |
Redmile Group, LLC | 769,641 | $32,802,000 | 2.48% |
Temasek Holdings (Private) Ltd | 5,833,568 | $248,627,000 | 2.36% |
SECTORAL ASSET MANAGEMENT INC | 1,088,118 | $46,376,000 | 2.12% |
Eventide Asset Management | 479,900 | $20,453,000 | 1.19% |
BBT Capital Management, LLC | 200,000 | $8,524,000 | 0.79% |